No registrations found.
ID
Source
Brief title
Health condition
supplementation of vitamins and fish oil fatty acids during pregnancy and lactation
breast milk
Sponsors and support
Intervention
Outcome measures
Primary outcome
the primary aim of the study is to find the dose of DHA during pregnancy and lactation that leads to a mean breast milk DHA of at least 0.7g%
Secondary outcome
The secundary aim of the study is to find the dose of vitamin D during pregnancy and lactation that causes a breast milk vitamin D content of 35 nmol/L and increasing breast milk vitamin B1, B2, B12, magnesium, iodide and selenium.
Background summary
-
Study objective
-
Study design
the first time point is at the start of the study at week 20 in the pregnancy.
The second time point (compliance) is week 36 of the pregnancy
The third time point and end point is 4 weeks after the delivery
Intervention
fish oil- fatty acids
vitamin D
multivitamin
Eline Stoutjesdijk;
UMCG hanzeplein 1
Groningen 9700 RB
The Netherlands
+31503610399
e.stoutjesdijk@umcg.nl
Eline Stoutjesdijk;
UMCG hanzeplein 1
Groningen 9700 RB
The Netherlands
+31503610399
e.stoutjesdijk@umcg.nl
Inclusion criteria
Change in inclusion criteria 26-06-2017:
apparently healthy women, during a non-complicated single pregnancy
BMI between 18 and 29 kg/m2 before pregnancy
good control of the Dutch language
willing to stop taking multivitamins, folic acid, vitamin D and fish oil supplements if taken
Exclusion criteria
hyperemesis graviradum
vegetarian or vegan
diabetes mellitus
criteria for individual ending of the study
preterm birth (gestational age less than 37 weeks) and birth after 42 weeks
complications mother
pregnancy diabetes
pre-eclampsia, placental insufficiency, intrauterine growth retardation
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL4835 |
| NTR-old | NTR4959 |
| CCMO | NL49639.042.14 |
| OMON | NL-OMON41801 |